Wed 25 Nov 2009 | 21:05 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. (HALO.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View HALO on other exchanges
As of  25 Nov 2009
5.98USD
Price Change
-0.14
Percent Change
-2.29%
 
Research Another Stock: Symbol Look-up

Name Total Annual Compensation Long-Term Incentive Plans All Other Fiscal Year Total
As Of 30 Dec 2008
Engler, Robert -- -- -- --
Falberg, Kathryn -- -- -- --
Fallon, William 270,000 -- 84,308 354,308
Frost, Gregory 323,000 -- 144,556 467,556
Gustafson, Kurt -- -- -- --
Kelley, Kenneth -- -- -- --
Kirk, Randal -- -- -- --
Leff, Jonathan -- -- -- --
Lim, Jonathan 375,000 -- 253,522 628,522
Little, Robert 322,000 -- 107,265 429,265
Matsui, Connie -- -- -- --
Patton, John -- -- -- --
Ramsay, David 260,000 -- 110,835 370,835
Shepard, H. Michael -- -- -- --